These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19303631)

  • 1. PCI or CABG in coronary artery disease?
    Taggart DP
    Lancet; 2009 Apr; 373(9670):1150-2. PubMed ID: 19303631
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.
    Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
    Cardiovasc Revasc Med; 2015 Mar; 16(2):70-7. PubMed ID: 25662779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.
    Campos CM; Stanetic BM; Farooq V; Walsh S; Ishibashi Y; Onuma Y; Garcia-Garcia HM; Escaned J; Banning A; Serruys PW;
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):E229-38. PubMed ID: 25946686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial clinical impact of drug eluting stents on coronary artery bypass graft surgery.
    Kanemitsu S; Tanaka K; Tanaka J; Suzuki H; Kinoshita T
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):632-5. PubMed ID: 17670720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry.
    Brilakis ES; Rao SV; Banerjee S; Goldman S; Shunk KA; Holmes DR; Honeycutt E; Roe MT
    JACC Cardiovasc Interv; 2011 Aug; 4(8):844-50. PubMed ID: 21851896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials.
    Hlatky MA; Boothroyd DB; Bravata DM; Boersma E; Booth J; Brooks MM; Carrié D; Clayton TC; Danchin N; Flather M; Hamm CW; Hueb WA; Kähler J; Kelsey SF; King SB; Kosinski AS; Lopes N; McDonald KM; Rodriguez A; Serruys P; Sigwart U; Stables RH; Owens DK; Pocock SJ
    Lancet; 2009 Apr; 373(9670):1190-7. PubMed ID: 19303634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stenting small vessels? Not a small issue.
    Bass TA
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):430-1. PubMed ID: 15274149
    [No Abstract]   [Full Text] [Related]  

  • 8. To excel or to confirm? That is the question.
    Dangas G
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):944. PubMed ID: 21598346
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.
    Head SJ; Holmes DR; Mack MJ; Serruys PW; Mohr FW; Morice MC; Colombo A; Kappetein AP;
    JACC Cardiovasc Interv; 2012 Jun; 5(6):618-25. PubMed ID: 22721656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing cost aspects of coronary artery bypass graft surgery with coronary artery stenting.
    Birim Ö; Bogers AJ; Kappetein AP
    J Cardiovasc Surg (Torino); 2012 Oct; 53(5):641-50. PubMed ID: 22252542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery.
    Kapoor JR; Gienger AL; Ardehali R; Varghese R; Perez MV; Sundaram V; McDonald KM; Owens DK; Hlatky MA; Bravata DM
    JACC Cardiovasc Interv; 2008 Oct; 1(5):483-91. PubMed ID: 19463349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitfalls assessing the role of drug-eluting stents in multivessel coronary disease.
    Desai ND
    Ann Thorac Surg; 2008 Jan; 85(1):25-7. PubMed ID: 18154771
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).
    Frutkin AD; Lindsey JB; Mehta SK; House JA; Spertus JA; Cohen DJ; Rumsfeld JS; Marso SP;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):614-21. PubMed ID: 19628183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous coronary intervention "dominates" coronary artery bypass graft surgery for high-risk patients: good news for patients, a challenge for healthcare planners.
    Radford MJ
    Circulation; 2006 Sep; 114(12):1229-31. PubMed ID: 16982950
    [No Abstract]   [Full Text] [Related]  

  • 15. Class I indications for coronary artery bypass graft surgery: what is the appropriate therapy for patients with multivessel coronary disease?
    Dean LS
    JACC Cardiovasc Interv; 2009 Jul; 2(7):622-3. PubMed ID: 19628184
    [No Abstract]   [Full Text] [Related]  

  • 16. Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data.
    Capodanno D; Stone GW; Morice MC; Bass TA; Tamburino C
    J Am Coll Cardiol; 2011 Sep; 58(14):1426-32. PubMed ID: 21939824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validating the EXCEL hypothesis: a propensity score matched 3-year comparison of percutaneous coronary intervention versus coronary artery bypass graft in left main patients with SYNTAX score ≤32.
    Capodanno D; Caggegi A; Capranzano P; Cincotta G; Miano M; Barrano G; Monaco S; Calvo F; Tamburino C
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):936-43. PubMed ID: 21547994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CABG vs angioplasty in kidney disease.
    Harv Heart Lett; 2012 Dec; 23(4):8. PubMed ID: 23476948
    [No Abstract]   [Full Text] [Related]  

  • 19. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.
    Serruys PW; Farooq V; Vranckx P; Girasis C; Brugaletta S; Garcia-Garcia HM; Holmes DR; Kappetein AP; Mack MJ; Feldman T; Morice MC; Ståhle E; James S; Colombo A; Pereda P; Huang J; Morel MA; Van Es GA; Dawkins KD; Mohr FW; Steyerberg EW
    JACC Cardiovasc Interv; 2012 Jun; 5(6):606-17. PubMed ID: 22721655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.